Table 2. Characteristics of Included Studies, Stated Preference for Cancer Screening, Systematic Review, 1990–2013.
| Citation | Population and Sample Size | Cancer type | Purpose of Study |
|---|---|---|---|
| Studies with only screening test attributes | |||
| Araña et al, 2006 (12) | 60 Students in Gran Canaria, Spain (compared preferences to those of 60 oncologists) | Cervical | Compare the preferences of general population with preferences of subjects with medical expertise. |
| Basen-Engquist et al, 2007 (13) | Women with (n = 457) and without (n = 449) a history of abnormal Papanicolaou smear who live in Groot-Rijnmond, Netherlands | Cervical | Compare the preferences of women with and without a history of abnormal Papanicolaou smear tests, including a new technology. |
| de Bekker-Grob et al, 2010 (14) | Adults aged 50–74 years with (n = 649) and without (n = 626) a colorectal cancer screening history in the Netherlands | Colorectal | Compare preference results for a labeled and an unlabeled discrete choice experiment. |
| Gyrd-Hansen, 2000 (15) | 207 Women aged 50 years living in Denmark | Breast | Assess women’s preferences for the attributes of breast cancer screening programs. |
| Gyrd-Hansen and Søgaard, 2001 (16) | 483 Adults aged 50 years living in Denmark | Colorectal | Assess women’s preferences for the attributes of colorectal cancer screening programs. |
| Hawley et al, 2008 (17) | 205 White, Hispanic, and African- American primary care patients aged 50–80 years with no personal or family history of colorectal cancer living in the United States | Colorectal | Describe preferences for a range of existing and new colorectal cancer screening tests among African American, Hispanic, and white primary care patients. |
| Hol et al, 2010 (18) | 489 Screening-naive adults aged 50–74 years and 545 subjects of a colorectal cancer screening trial also aged 50–74 years living in the Netherlands | Colorectal | Assess preferences and predict the uptake of colorectal cancer screening programs and identify differences in preference structures among subgroups in the sample. |
| Howard and Salkeld, 2009 (19) | 1,150 People who had purchased a fecal occult blood test in the past year who were living in Australia | Colorectal | Explore the effect of attribute framing on colorectal cancer screening preferences. |
| Howard et al, 2011 (20) | 130 Patients with clinical indications suspicious of colorectal cancer who experienced both CTC and colonoscopy who are living in South Australia | Colorectal | Assess preferences of patients with suspicious clinical indications of colorectal cancer who have experienced both CTC and colonoscopy. |
| Marshall et al, 2007 (21) | 547 Primary care patients aged 40–60 years living in Canada | Colorectal | Measure and quantify preferences for various colorectal cancer screening tests and predictors of uptake. |
| Marshall et al, 2009 (22) | 501 General population respondents living in Canada and 1,087 living in the United States (compared with physicians) | Colorectal | Compare preferences of the general population and physicians for attributes of colorectal cancer screening tests and predictors of uptake. |
| Pignone et al, 2012 (23) | 104 Adults aged 48–75 years with no personal or immediate family history of colon cancer, polyps, or inflammatory bowel disease living in the United States | Colorectal | Compare preferences elicited using choice-based conjoint analysis and a rating and ranking task for colorectal cancer screening tests. |
| Ryan and Skåtun, 2004 (24) | 491 Women aged 18–65 years eligible for screening for cervical cancer and living in Scotland, United Kingdom | Cervical | Explore the importance of including an opt-out or no-test option in discrete-choice studies. |
| van Dam et al, 2010 (25) | 152 Screening-naive individuals aged 50–74 years and 120 screening trial participants of average colorectal cancer risk living in the Netherlands | Colorectal | Compare preferences for attributes of 3 common colorectal cancer screening tests. |
| Wordsworth et al, 2006 (26) | 577 Women aged 18–65 years eligible for screening for cervical cancer and living in Scotland, United Kingdom | Cervical | Elicit preferences for the attributes of cervical cancer screening tests. |
| Studies with only health care delivery attributes | |||
| Griffith et al, 2009 (27) | 120 Patients at high, moderate, and low risk of developing genetic cancer who received a genetic risk assessment and live in Wales, United Kingdom | Breast | Compare the preferences for attributes of genetic screening tests among women at low, moderate, and high risk of carrying a genetic mutation. |
| Peacock et al, 2006 (28) | 339 Ashkenazi Jewish women living in Australia who enrolled in a study to test for mutations in the genes BRCA1 and BRCA2 | Breast | Assess preferences for attributes of breast cancer genetic counseling services among Ashkenazi Jewish women. |
| Studies with both screening test and health care delivery attributes | |||
| Fiebig et al, 2009 (29) | 167 Women in Australia aged 18–69 years previously screened for cervical cancer (compared with general practitioners) | Cervical | Compare the preferences of consumers and providers for attributes of alternative cervical screening tests. |
| Gerard et al, 2003 (30) | 87 Women in Australia attending breast cancer screening | Breast | Assess preferences for alternative breast cancer screening options and illustrate how breast cancer screening service providers can use empirical findings to develop preferred participation strategies. |
| Nayaradou et al, 2010 (31) | 656 Members of the general population living in France aged 50–74 years | Colorectal | Assess preferences for different types of the fecal occult blood test, a colorectal cancer screening test. |
| Salkeld et al, 2000 (32) | 336 People living in Australia who had used the bowel scan test kit on at least 2 occasions in the previous 3 years | Colorectal | Compare consumer preferences for an existing colorectal cancer test with a new test. |
| Salkeld et al, 2003 (33) | 301 Adults living in Australia aged 50–70 years at “average” risk of colorectal cancer | Colorectal | Elicit preferences for attributes of colorectal cancer screening using the fecal occult blood test. |
Abbreviations: BRCA1 and BRCA2, breast cancer 1 and 2, early onset genes; CTC, computed tomography colonography.